Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001790340-24-000080
Filing Date
2024-11-13
Accepted
2024-11-13 16:09:31
Documents
66
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q imrx-20240930.htm   iXBRL 10-Q 1577836
2 EX-31.1 imrx-20240930xex311.htm EX-31.1 10263
3 EX-31.2 imrx-20240930xex312.htm EX-31.2 10383
4 EX-32.1 imrx-20240930xex321.htm EX-32.1 5131
5 EX-32.2 imrx-20240930xex322.htm EX-32.2 5272
  Complete submission text file 0001790340-24-000080.txt   6263446

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT imrx-20240930.xsd EX-101.SCH 36161
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT imrx-20240930_cal.xml EX-101.CAL 56210
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT imrx-20240930_def.xml EX-101.DEF 228300
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT imrx-20240930_lab.xml EX-101.LAB 517073
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT imrx-20240930_pre.xml EX-101.PRE 379799
68 EXTRACTED XBRL INSTANCE DOCUMENT imrx-20240930_htm.xml XML 675617
Mailing Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142
Business Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142 617-500-8080
Immuneering Corp (Filer) CIK: 0001790340 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40675 | Film No.: 241454223
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)